- » Aim and Scope
- » Section Policies
- » Publication Frequency
- » Open Access Policy
- » Archiving
- » Peer-Review
- » Indexation
- » Publishing Ethics
- » Founder
- » Author fees
- » Disclosure and Conflict of Interest
- » Plagiarism detection
- » Preprint and postprint Policy
- » Advertising policy of "Tuberculosis and Lung Diseases" Journal
Aim and Scope
The Journal is aimed for professional development of researchers, doctors, teachers of medical universities and training institutions. The Journal focuses on the presentation of results of research, case studies, issues of differential diagnostics and treatment in the phthisiologist’s practice, national programs on tuberculosis control in the Russian Federation, WHO strategies, discussion of prevention issues to stop transmission of TB/HIVco-infection, and extrapulmonary tuberculosis.
Section Policies
Open Submissions Open Submissions |
Indexed |
Peer Reviewed |
| Open Submissions |
Indexed |
Peer Reviewed |
| Open Submissions |
Indexed |
Peer Reviewed |
| Open Submissions |
Indexed |
Peer Reviewed |
Publication Frequency
6 issues per year
Open Access Policy
"Tuberculosis and Lung Diseases" is an open access journal. All articles are made freely available to readers immediatly upon publication.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition - it means that articles have free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.
For more information please read BOAI statement.
Archiving
- Russian State Library (RSL)
- National Electronic-Information Consortium (NEICON)
- Russian Book Chamber
Peer-Review
The Journal uses double blind peer reviewing of the submitted manuscripts. The reviewer is provided with the manuscript without mentioning of the authors' names. The author is not aware who the reviewer is. The author and reviewer exchange letters through the email address of the editorial staff.
The publisher reviews all materials submitted to the editorial office with the purpose of their expert evaluation including their compliance with the journal profile. All referees are acknowledged specialists in the topics of the journal profile and their manuscripts have been published in the journal the last 3 years.
In the case of a negative review, manuscripts are not to be published and not sent back to the authors. In the case of a positive review, they may be sent to the authors to improve them or to delete items.
Upon the author's inquiry, the copy of the review or motivated refusal is provided.
The reviewer performs the scientific expert evaluation of the author's materials, the evaluation is to be unbiased and compliant with the following rules:
- expert evaluation is to assist to the author to enhance the quality of the manuscript's text and to the chief editor to make the decision about publication,
- the reviewer who does not consider him/herself a specialist in the field of the manuscript or is aware that he/she would be unable to provide the review in due time should notify the Editor-in-Chief of it and abstain from reviewing,
- the author or co-author of the manuscript can not be the reviewer as well as academic advisors of post-graduate students and/or those working together with the author in the same department,
- any manuscript received from the editor for review is a confidential document. It should not be discussed with someone else but for those mentioned by the Editor-in-Chief.
- The reviewer is to be free of prejudices. Personal remarks to the author are not allowed. The reviewer's opinion is to be expressed clearly and reasonably.
- The reviewer is to draw the attention of the Editor-in-Chief to the significant similarity or partially overlapping the reviewed manuscript with any other one published before.
Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript and should recuse themselves from reviewing specific manuscripts if the potential for bias exists.
When making a decision on publication the Editor-in-Chief seeks the advice from the editorial board and/or reviewers.
The Editor-in-Chief of «Tuberculosis and Lung Diseases» Journal is responsible for decision making on the publication of the submitted materials, deciding on the reliability and importance of the research for researchers and readers, compliance with legal requirements (violation of the copyright, plagiarism, and libel).
Indexation
Articles in "Tuberculosis and Lung Diseases" are indexed by several systems:
- Russian Scientific Citation Index (RSCI) – a database, accumulating information on papers by Russian scientists, published in native and foreign titles. The RSCI project is under development since 2005 by “Electronic Scientific Library” foundation (elibrary.ru).
- Google Scholar is a freely accessible web search engine that indexes the full text of scholarly literature across an array of publishing formats and disciplines. The Google Scholar index includes most peer-reviewed online journals of Europe and America's largest scholarly publishers, plus scholarly books and other non-peer reviewed journals.
- Scopus
- Dimensions
- DOAJ
- SOCIONET
- Base
- NLM Catalog
- VINITI RAS
- WorldCat
- EDS
Publishing Ethics
- General Provisions
The editors, editorial staff and NEW TERRA Private Limited Liability Company as a publisher of Journal Tuberculosis and Lung Diseases adhere to ethic standards of the international scientific society and strive to prevent any violations of these norms.
The editors, editorial staff and publisher of the Journal base their activities on the code and recommendations of Committee on Publication Ethics (COPE) as well as pay special attention to the experience of reputable international journals and publishing houses.
Below are the ethical code principles mandatory for all parties involved into the review and publication of a manuscript: author(s), reviewers, editors, editorial staff and publisher of the Journal.
Adherence to the ethical code by all participants would ensure the compliance with intellectual property rights, enhance the quality of the Journal in the eyes of the international scientific society and prevent unlawful use of the authors’ materials for the benefit of other parties.
- Authors’ Responsibilities
Authors are personally responsible for the text of the manuscript they submit, which means complying with the following rules:
- The original manuscript as submitted should not be under consideration for publication or published earlier elsewhere,
- Research results described in the manuscript are to be obtained through independent and original study, Excessive adoptions, any plagiarism including quotations without references, rephrasing or capture the right for results of someone else’s research are unethical and unacceptable. The manuscripts compiled from materials published earlier by some other authors without original revision and personal reasoning of the author are not accepted for publication in the Journal,
- Submission of reliable results of the conducted research or work,
- Acknowledgment of all those contributing to the progress or defining the character of the research. In particular the manuscript is to include references to Russian and foreign publications which were valuable for the research,
- All those making significant intellectual contribution into the manuscript’s concept and structure, as into conduction of the research or interpretation of the results are be mentioned as co-authors. Gratitude is to be expressed to the other participating in certain aspects of the research. No one not involved into the research is to be mentioned as a co-author,
- Should some significant errors or inaccuracy be identified in the manuscript while it is being reviewed or after it has been published, the editors are to be notified of this immediately and some joint decision is to be taken about confessing the error and/or its correction within the shortest period of time. Should the editors learn from a third party that the published manuscript contains significant errors, the author must immediately remove or correct such errors or provide the editors with the proves that submitted information is correct,
- All funders of the research are to be mentioned,
- The author should declare any conflict of interests which can exert certain influence on the research results, their interpretation and the opinion of the reviewers.
- Reviewers’ Responsibilities
The reviewer performs the scientific expert evaluation of the author’s materials, the evaluation is to be unbiased and compliant with the following rules:
- Expert evaluation is to assist to the author to enhance the quality of the manuscript’s text and to the Editor-in-Chief to make the decision about publication,
- The reviewer who does not consider him/herself a specialist in the field of the manuscript or is aware that he/she would be unable to provide the review in due time should notify the Editor-in-Chief of it and abstain from reviewing,
- The author or co-author of the manuscript can not be the reviewer as well as academic advisors of post-graduate students and/or those working together with the author in the same department,
- Any manuscript received from the editor for reviewing is confidential. It should not be discussed with someone else but for those mentioned by the Editor-in-Chief,
- The reviewer is to be free of prejudices. Personal remarks to the author are not allowed. The reviewer’s opinion is to be expressed clearly and reasonably,
- The reviewer is to draw the attention of the Editor-in-Chief to the significant similarity or partial overlapping the reviewed manuscript with any other one published before.
- Editors’ Responsibilities
The editors and editorial board members are responsible for public exposure of the authors’ manuscripts which implies adherence to the following rules:
- Implementing independent policy for selection and publication of the materials presenting scientific and practical research,
- Ensuring compliance of the published materials with accepted international standards and ethical code,
- Enhancement of the Journal quality for maximum satisfaction of readers and authors,
- Cooperation with authors and reviewers in order to provide the high quality of the published materials,
- Rejection or acceptance for publication is to be based on importance, originality, clarity and relevance of the research with the consideration of its intellectual content without any discrimination on grounds of race, gender, sexual orientation, religion, ethnic origin, nationality or political belief of the author,
- Publication of the materials reflecting different scientific opinions, with the right to abridge, edit and adapt the materials to be published, respective headings of the Journal,
- Confession of committed errors and if necessary publication of corrections, clarifications, refutations and apologies.
The Editor-in-Chief of Journal Tuberculosis and Lung Diseases is responsible for decision making on the publication of the submitted materials, deciding on the reliability and importance of the research for researchers and readers, compliance with legal requirements (violation of the copyright, plagiarism and libel).
When making decision on publication the Editor-in-Chief seeks the advice from the editorial board or reviewers.
- Publisher’s Responsibility
While performing its duties the publisher is responsible for public exposure of the authors’ manuscripts which implies adherence to the following rules:
- Assisting in fulfillment of ethical responsibilities of the editors, editorial board, reviewers and authors in compliance with the above requirements,
- Supporting the editors in reviewing claims to ethical aspects of the published materials and assisting in cooperation with other journals and/or publishers if it is useful for editors during performance of their duties,
- Assuring confidentiality of all information received from the authors till its publication,
- Confidence that potential profit from advertisement will not exert influence on the decision making by the editors on acceptance of the manuscript for publication,
- Promptitude in the publication of corrections, explanations, refutation and apologies when necessary,
- Provision of the editorial board with the opportunity to exclude publications containing plagiarism and unreliable data.
Informed consent and human and animal rights
Research and practical activities of "Tuberculosis and Lung Diseases" Journal are based on WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects and the journal team strives for complying with ethical norms and rules for data collection for research involving human subjects.
Medical research involving human subjects must conform to generally accepted scientific principles, be based on a thorough knowledge of the scientific literature, other relevant sources of information, and adequate laboratory and, as appropriate, animal experimentation. The welfare of animals used for research must be respected.
Before starting any research the researcher should familiarize him/herself with provisions on the informed consent of WMA Declaration of Helsinki and perform the research in the strict compliance with the principles presented below (Items 25-31 of WMA Declaration of Helsinki:
25. Participation by individuals capable of giving informed consent as subjects in medical research must be voluntary. Although it may be appropriate to consult family members or community leaders, no individual capable of giving informed consent may be enrolled in a research study unless he or she freely agrees.
26. In medical research involving human subjects capable of giving informed consent, each potential subject must be adequately informed of the aims, methods, sources of funding, any possible conflicts of interest, institutional affiliations of the researcher, the anticipated benefits and potential risks of the study and the discomfort it may entail, post-study provisions and any other relevant aspects of the study. The potential subject must be informed of the right to refuse to participate in the study or to withdraw consent to participate at any time without reprisal. Special attention should be given to the specific information needs of individual potential subjects as well as to the methods used to deliver the information.
After ensuring that the potential subject has understood the information, the physician or another appropriately qualified individual must then seek the potential subject’s freely-given informed consent, preferably in writing. If the consent cannot be expressed in writing, the non-written consent must be formally documented and witnessed.
All medical research subjects should be given the option of being informed about the general outcome and results of the study.
27. When seeking informed consent for participation in a research study the physician must be particularly cautious if the potential subject is in a dependent relationship with the physician or may consent under duress. In such situations, the informed consent must be sought by an appropriately qualified individual who is completely independent of this relationship.
28. For a potential research subject who is incapable of giving informed consent, the physician must seek informed consent from the legally authorized representative. These individuals must not be included in a research study that has no likelihood of benefit for them unless it is intended to promote the health of the group represented by the potential subject, the research cannot instead be performed with persons capable of providing informed consent, and the research entails only minimal risk and minimal burden.
29. When a potential research subject who is deemed incapable of giving informed consent is able to give assent to decisions about participation in research, the physician must seek that assent in addition to the consent of the legally authorized representative. The potential subject’s dissent should be respected.
30. Research involving subjects who are physically or mentally incapable of giving consent, for example, unconscious patients, may be done only if the physical or mental condition that prevents giving informed consent is a necessary characteristic of the research group. In such circumstances, the physician must seek informed consent from the legally authorized representative. If no such representative is available and if the research cannot be delayed, the study may proceed without informed consent provided that the specific reasons for involving subjects with a condition that renders them unable to give informed consent have been stated in the research protocol and the study has been approved by a research ethics committee. Consent to remain in the research must be obtained as soon as possible from the subject or a legally authorized representative.
31. The physician must fully inform the patient which aspects of their care are related to the research. The refusal of a patient to participate in a study or the patient’s decision to withdraw from the study must never adversely affect the patient-physician relationship.
32. For medical research using identifiable human material or data, such as research on material or data contained in biobanks or similar repositories, physicians must seek informed consent for its collection, storage and/or reuse. There may be exceptional situations where consent would be impossible or impracticable to obtain for such research. In such situations, the research may be done only after consideration and approval of a research ethics committee.
When submitting results of experimental research involving human subjects the authors should specify if the performed procedures compiled with the code of ethics provided in WMA Declaration of Helsinki. If principles of WMA Declaration of Helsinki were not considered during the research, the authors should justify their approach to the research and guarantee that the ethics committee of the organization where the research was conducted approved of such an approach.
Author fees
Publication in "Tuberculosis and Lung Diseases" is free of charge for all the authors.
The journal doesn't have any Arcticle processing charges.
The journal doesn't have any Article submission charges.
Disclosure and Conflict of Interest
The editorial team adheres to the guidelines of JCMJE (INTERNATIONAL COMMITTEE OF MEDICAL JOURNAL EDITORS)
When authors submit a manuscript they are responsible for disclosing all financial and personal relationships that might bias their work. In order to avoid ambiguity authors should explicitly state if there is any potential conflict of interest. Conflict of Interest Disclosure Form can be downloaded here. The completed form is submitted to the journal along with the manuscript. If necessary additional details can be provided in the supporting letter which is to be provided along with the manuscript.
The editor makes a decision on the publication of information provided by the authors about the potential conflict of interest. Should there be any doubts the editors may refrain from publication of the manuscript.
Complying with the ethical code researchers should provide valid results of the research for publication. Moreover being directly responsible for their work, researchers should avoid entering into agreements that interfere with authors’ access to the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently. Authors should inform about a sponsor (sponsors) along with explanations of the role of those sources if any in study design; collection, analysis, and interpretation of data; writing of the report; the decision to submit the report for publication.
Editors may request that authors of a study sponsored by a funder with a proprietary or financial interest in the outcome sign a statement, such as “I had full access to all of the data in this study and I take complete responsibility for the integrity of the data and the accuracy of the data analysis.” Editorial staff can reject considering the manuscript if the sponsor declares his author's rights for publication.
The editors should not appoint external reviewers if there is an obvious potential conflict of interest.
Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript and should recuse themselves from reviewing specific manuscripts if the potential for bias exists.
Reviewers must not use knowledge of the work they’re reviewing before its publication to further their own interests.
The editor who makes final decisions about manuscripts should have no private, professional or financial interest/involvement in any issue within his/her field of authority. Other editorial staff members who participate in editorial decisions must provide editors with a current description of their financial interests or other conflicts (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists.
Editorial staff must not use information gained through working with manuscripts for private gain. Editors should publish regular disclosure statements about potential conflicts of interests related to the commitments of journal staff.
Unpublished data obtained from manuscripts submitted for review are not to be used for someone's own research without written approval of the author.
Information or ideas obtained through reviewing and related to certain advantages must be kept confidential and not used for any personal benefit.
Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
Plagiarism detection
"Tuberculosis and Lung Diseases" use native russian-language plagiarism detection software Antiplagiat to screen the submissions. If plagiarism is identified, the COPE guidelines on plagiarism will be followed.
Preprint and postprint Policy
Prior to acceptance and publication in "Tuberculosis and Lung Diseases", authors may make their submissions available as preprints on personal or public websites.
As part of submission process, authors are required to confirm that the submission has not been previously published, nor has been submitted. After a manuscript has been published in "Tuberculosis and Lung Diseases" we suggest that the link to the article on journal's website is used when the article is shared on personal or public websites.
Glossary (by SHERPA)
Advertising policy of "Tuberculosis and Lung Diseases" Journal
The Journal derives certain income from advertising or reprints, therefore the advertising policy of the Journal has been approved and its main principles are presented below:
- Editorial decisions should not be influenced by advertising revenue or reprint potential.
- Editorial and advertising functions at the journal should be independent.
- Advertisers and donors should have no control over editorial material under any circumstances.
- Reprinted articles must be published as they originally appeared in the journal (including subsequent corrections); that is, there is no alteration or revision of articles for a supplement or reprint other than corrections.
- The content of special supplementary issues (if any) should be determined only by the usual editorial process and not be influenced in any way by the funding source or advertisers.
- Advertisements or endorsements of a product or company should not exceed 40% of the total content of the journal.
- Journals should have a formal advertising policy and this should be made available to all constituents of the journal.
- Briefly, journals should require all advertisements to clearly identify the advertiser and the product or service being offered. In the case of drug advertisements, the full generic name of each active ingredient should appear.
- Commercial advertisements should not be placed adjacent to any editorial matter that discusses the product being advertised, nor adjacent to any article reporting research on the advertised product, nor should they refer to an article in the same issue in which they appear.
- Ads should have a different appearance from editorial material so there is no confusion between the two.
- Advertisements may not be deceptive or misleading. Exaggerated or extravagantly worded copy should not be allowed. Advertisements should not be accepted if they appear to be indecent or offensive or contain negative content of a religious and/or racial character.
- Products being advertised should be germane to the practice of medicine, medical education, or health care delivery.
- Journals must have the right to refuse any advertisement for any reason.
- The decision as to acceptance should be made in consultation with the journal's editor and editorial content team.
The above text is based on Recommendations on Publication Ethics Policies for Medical Journals WAME.
